2021
DOI: 10.1177/19714009211017799
|View full text |Cite
|
Sign up to set email alerts
|

Percutaneous spine biopsy under cone beam computed tomography guidance for spondylodiscitis: Time is diagnosis

Abstract: Background and purpose Percutaneous spine biopsies for spondylodiscitis have been long discussed due to the low microbiologic yield. This retrospective study evaluated factors of cone beam computed tomography-guided spine biopsies that may affect microbiologic yield. Methods We retrospectively reviewed percutaneous spine biopsies under cone beam computed tomography for spondylodiscitis performed from January 2015–December 2020. Clinical and technical features such as the time from initial symptoms to biopsy, l… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…16 Specifically for any infectious substrate, sampling of both the vertebral end plate and the intervertebral disk, as well as discontinuation of antibiotics before biopsy, were shown to increase the procedure's diagnostic yield and reduce the need for repeated biopsies. 17,18 The complications rate is < 5% including vascular injury, hematoma, myelopathy, nerve root damage and radiculopathy, thecal sac puncture, and fracture. 19…”
Section: Percutaneous Biopsymentioning
confidence: 99%
“…16 Specifically for any infectious substrate, sampling of both the vertebral end plate and the intervertebral disk, as well as discontinuation of antibiotics before biopsy, were shown to increase the procedure's diagnostic yield and reduce the need for repeated biopsies. 17,18 The complications rate is < 5% including vascular injury, hematoma, myelopathy, nerve root damage and radiculopathy, thecal sac puncture, and fracture. 19…”
Section: Percutaneous Biopsymentioning
confidence: 99%